Drug Interactions Between Cyproheptadine and Lamotrigine, Aripiprazole, Topical Minoxidil, and Finasteride
No clinically significant drug-drug interactions are documented between cyproheptadine and lamotrigine (Lamictal), aripiprazole (Abilify), topical minoxidil, or finasteride based on available evidence.
Interaction Analysis by Drug Pair
Cyproheptadine + Lamotrigine (Lamictal)
- No documented interaction in standard references
- One case report describes concurrent use of cyproheptadine to treat serotonin toxicity in a patient who overdosed on both lamotrigine and citalopram, where cyproheptadine successfully resolved symptoms within 3 days 1
- This demonstrates cyproheptadine can be safely used even in the presence of lamotrigine
- Clinical implication: No dose adjustment needed for either medication
Cyproheptadine + Aripiprazole (Abilify)
- No documented interaction in FDA labeling or guidelines
- Cyproheptadine is a serotonin antagonist (5-HT2A blocker) while aripiprazole is a partial dopamine agonist with serotonin modulating properties 2, 3
- Both have sedating properties, which could theoretically be additive
- Clinical implication: Monitor for increased sedation or drowsiness, but no contraindication exists
Cyproheptadine + Topical Minoxidil
- No interaction expected - topical minoxidil has minimal systemic absorption (less than 5% absorbed through skin) 4
- Cyproheptadine is an antihistamine with anticholinergic properties; minoxidil is a vasodilator 5, 6
- Even with twice-daily 5% topical minoxidil application, blood levels remain well below concentrations that cause hemodynamic effects 4
- Clinical implication: No precautions needed; these can be used together safely
Cyproheptadine + Finasteride
- No documented interaction in available literature
- Finasteride is a 5-alpha reductase inhibitor with no known interaction with antihistamines 7, 8, 9, 10
- Different mechanisms of action with no overlapping metabolic pathways
- Clinical implication: Safe to use concurrently without dose adjustment
Important Considerations for Cyproheptadine Use
Sedation and Anticholinergic Effects
Cyproheptadine's primary concerns relate to its inherent properties rather than drug interactions:
- Sedation: Can impair driving and cognitive function 11
- Anticholinergic effects: Particularly concerning in elderly patients, associated with cognitive decline 11
- Cardiovascular concerns: Some concern exists for use in patients prone to cardiovascular events 11
Serotonin Syndrome Context
Cyproheptadine is actually used as a treatment for serotonin syndrome due to its 5-HT2A antagonist properties 2, 12:
- Typical dosing: 12 mg initially, then 2 mg every 2 hours for continuing symptoms 2
- Pediatric dosing: 0.25 mg/kg per day 2
- This therapeutic use demonstrates it counteracts rather than potentiates serotonergic effects
Practical Clinical Guidance
You can safely prescribe this combination with the following monitoring:
- Watch for additive sedation (cyproheptadine + aripiprazole both cause drowsiness)
- Counsel patients about potential drowsiness affecting driving or operating machinery
- In elderly patients, monitor for anticholinergic side effects (confusion, dry mouth, urinary retention)
- No laboratory monitoring or dose adjustments required based on drug-drug interactions alone
The absence of documented interactions across multiple high-quality guidelines 2, 5, 11, 12, 13, 11 and the FDA label for Abilify 3 provides reassurance that this combination lacks clinically significant pharmacokinetic or pharmacodynamic interactions.